Yerkebulan Kambarov

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Cross Sectional

End Stage Renal Disease

Patient Reported Outcomes

Top Venues

Advances in therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Katalin Pungor, Jennifer Lee, Tom R Denee, Yerkebulan Kambarov, Riikka Nissinen, Kevin Ampeh, Marco Pellegrini, Francesco Parmeggiani
Impacts of X-linked Retinitis Pigmentosa and Patient Pathways in European Countries: Results from the Cross-sectional EXPLORE XLRP-1 Physician Survey. Advances in therapy 41 (8) (2024)
Katalin Pungor, Jennifer Lee, Tom R Denee, Yerkebulan Kambarov, Riikka Nissinen, Kevin Ampeh, Marco Pellegrini, Francesco Parmeggiani
Impacts of X-linked Retinitis Pigmentosa and Patient Pathways in European Countries: Results from the Cross-sectional EXPLORE XLRP-1 Physician Survey. Advances in therapy 41 (8) (2024)
Katalin Pungor, Jennifer Lee, Tom R Denee, Yerkebulan Kambarov, Riikka Nissinen, Kevin Ampeh, Marco Pellegrini, Francesco Parmeggiani
Impacts of X-linked Retinitis Pigmentosa and Patient Pathways in European Countries: Results from the Cross-sectional EXPLORE XLRP-1 Physician Survey. Advances in therapy (2024)
Katalin Pungor, Jennifer Lee, Tom R Denee, Yerkebulan Kambarov, Riikka Nissinen, Kevin Ampeh, Marco Pellegrini, Francesco Parmeggiani
Impacts of X-linked Retinitis Pigmentosa and Patient Pathways in European Countries: Results from the Cross-sectional EXPLORE XLRP-1 Physician Survey. Advances in therapy 41 (8) (2024)
Albino J Oliveira-Maia, Ania Bobrowska, Eric Constant, Tetsuro Ito, Yerkebulan Kambarov, Hannah Luedke, Siobhán Mulhern-Haughey, Christian von Holt
Treatment-Resistant Depression in Real-World Clinical Practice: A Systematic Literature Review of Data from 2012 to 2022. Advances in therapy (2023)